Format

Send to

Choose Destination
See comment in PubMed Commons below
Toxicol Ind Health. 2009 Oct-Nov;25(9-10):711-4. doi: 10.1177/0748233709348281.

The treatment of patients with mycotoxin-induced disease.

Author information

1
Environmental Health Center-Dallas, Dallas, TX 75231, USA. wjr@ehcd.com

Abstract

Twenty-eight incapacitated individuals (average 43 years old, 7 males, 21 females, range 12-70) exposed to molds and mycotoxins were studied and treated with a protocol of cleaning up or changing their environment to be mold free. Injections of the optimum dose of antigens were given as part of the treatment protocol as was oral and intravenous (i.v.) antioxidants; heat depuration (sauna); physical therapy with massage and exercise under environmentally controlled conditions; oxygen therapy at 4-8 L/min for 2 hours with a special wood-grade cellophane reservoir and a glass oxygen container. Many patients were sensitive to plastics; therefore, exposures to these were kept to a minimum. Autogenous lymphocytic factor was given as an immune modulator. Of 28 patients, 27 did well and returned to work. One patient improved but did not return to work during the period of study.

PMID:
19854821
DOI:
10.1177/0748233709348281
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon
    Loading ...
    Support Center